B. Helbling et J. Reichen, REACTIVATION OF HEPATITIS-B AFTER CHLOROQUINE WITHDRAWAL, Schweizerische medizinische Wochenschrift, 124(18), 1994, pp. 759-762
A severe flare-up of chronic hepatitis B infection with liver cell ins
ufficiency has been observed in two patients after discontinuation of
chloroquine administered either as malaria prophylaxis or as treatment
of presumed rheumatoid arthritis. Chloroquine is known to inhibit the
association of the major histocompatibility complex type II with hepa
titis B virus antigens, thereby inhibiting T-cell mediated lysis of in
fected cells. Furthermore, it inhibits uptake of duck hepatitis B viru
s by duck liver cells. These in vitro studies and our clinical observa
tions suggest that chloroquine inhibits lysis of hepatitis B virus inf
ected hepatocytes. Withdrawal of chloroquine in patients with chronic
hepatitis B virus infection can lead to a rebound immune response mani
festing as a reactivation of hepatitis B, similar to that observed aft
er steroid withdrawal.